home / stock / imund / imund quote
Last: | $5.25 |
---|---|
Change Percent: | -8.54% |
Open: | $5.75 |
Close: | $5.25 |
High: | $5.75 |
Low: | $5.25 |
Volume: | 573 |
Last Trade Date Time: | 06/03/2021 04:41:46 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.25 | $5.75 | $5.25 | $5.75 | $5.25 | 573 | 06-03-2021 |
$5.74 | $5.74 | $5.74 | $5.74 | $5.74 | 566 | 06-02-2021 |
$5.5 | $5.5 | $5.5 | $5.5 | $5.25 | 1,336 | 06-01-2021 |
$5.83 | $6 | $5.83 | $6 | $5.83 | 300 | 05-31-2021 |
$5.83 | $6 | $5.83 | $6 | $5.83 | 300 | 05-28-2021 |
$6 | $6 | $6 | $6 | $6 | 178 | 05-27-2021 |
$6.5 | $6.01 | $6.5 | $6.5 | $6 | 913 | 05-26-2021 |
$6 | $8.05 | $6 | $9.648 | $5.905 | 10,203 | 05-25-2021 |
$7.5 | $7.5 | $7.5 | $7.5 | $7.5 | 2,004 | 05-24-2021 |
$8.5 | $7.19 | $8.5 | $10 | $7.19 | 1,374 | 05-21-2021 |
$5.2 | $6.16 | $5.2 | $6.16 | $5 | 3,150 | 05-20-2021 |
$7 | $7.2 | $7 | $7.5 | $6.5 | 2,438 | 05-19-2021 |
$7 | $7.25 | $7 | $7.25 | $7 | 692 | 05-18-2021 |
$7.25 | $7.01 | $7.25 | $7.25 | $7.01 | 1,818 | 05-17-2021 |
$8 | $8 | $8 | $8 | $2.55 | 4,854 | 05-14-2021 |
$13.15 | $13.15 | $13.15 | $13.15 | $13.15 | 457 | 05-13-2021 |
$16 | $16 | $16 | $16 | $16 | 168 | 05-12-2021 |
$13.5 | $19.95 | $13.5 | $19.95 | $13.5 | 1,013 | 05-11-2021 |
$12.9 | $19.81 | $12.9 | $19.81 | $12 | 777 | 05-10-2021 |
News, Short Squeeze, Breakout and More Instantly...
Immune Therapeutics Company Name:
IMUND Stock Symbol:
OTCMKTS Market:
Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp (OTC Pink: IMUN) (“Biostax”), a hub and spoke biotech development engine, sadly announces the passing of H. Louis Salomonksy, a dedicated member of its Board of Directors. Mr. Salomonksy pas...
Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp . (OTC Pink: IMUN) (“Biostax”), a hub-and-spoke biotech development engine, announces the signing of a research collaboration agreement with Immgenuity, Inc . The joint resear...
Orlando, FL, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) ("Biostax"), a hub-and-spoke biotech development engine, announces that they have accepted the transfer of three Investigational New Drug Applications (IND) for the drug candidate, JKB-12...